{"transactions":[{"id":744802,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-10T01:20:49.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date."}],"balance_after":16667,"derivative":{"exercise_price":21.23,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001628280-26-042039","document":"wk-form4_1781054445.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000162828026042039/wk-form4_1781054445.xml","form_type":"4"}},{"id":744801,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T01:20:49.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":5778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date."}],"balance_after":27901,"source":{"system":"sec-edgar","filing":"0001628280-26-042039","document":"wk-form4_1781054445.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000162828026042039/wk-form4_1781054445.xml","form_type":"4"}},{"id":997935,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-18T01:38:17.000Z","date":"2025-11-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3490,"price":3.25,"value":11342.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards."}],"balance_after":99356,"source":{"system":"sec-edgar","filing":"0001193125-25-285005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000119312525285005/ownership.xml","form_type":"4"}},{"id":997934,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-11-18T00:56:39.000Z","date":"2025-11-13","kind":"exercise","planned":true,"acquired":false,"shares":12220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on August 14, 2025, by the Reporting Person, with a plan end date of November 2, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023."}],"balance_after":0,"derivative":{"exercise_price":7.51,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":12220},"source":{"system":"sec-edgar","filing":"0001866171-25-000007","document":"wk-form4_1763427396.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000186617125000007/wk-form4_1763427396.xml","form_type":"4"}},{"id":997933,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-11-18T00:56:39.000Z","date":"2025-11-13","kind":"exercise","planned":true,"acquired":false,"shares":27052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on August 14, 2025, by the Reporting Person, with a plan end date of November 2, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 14, 2024, subject to the non-employee director's continuous service."}],"balance_after":0,"derivative":{"exercise_price":8.63,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":27052},"source":{"system":"sec-edgar","filing":"0001866171-25-000007","document":"wk-form4_1763427396.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000186617125000007/wk-form4_1763427396.xml","form_type":"4"}},{"id":997932,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-18T00:56:39.000Z","date":"2025-11-13","kind":"sale","planned":true,"acquired":false,"shares":1232,"price":23.37,"value":28791.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on August 14, 2025, by the Reporting Person, with a plan end date of November 2, 2026."}],"balance_after":22123,"source":{"system":"sec-edgar","filing":"0001866171-25-000007","document":"wk-form4_1763427396.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000186617125000007/wk-form4_1763427396.xml","form_type":"4"}},{"id":997931,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-18T00:56:39.000Z","date":"2025-11-13","kind":"sale","planned":true,"acquired":false,"shares":39272,"price":23.1896,"value":910701.9712,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on August 14, 2025, by the Reporting Person, with a plan end date of November 2, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $22.86 to $23.60, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":23355,"source":{"system":"sec-edgar","filing":"0001866171-25-000007","document":"wk-form4_1763427396.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000186617125000007/wk-form4_1763427396.xml","form_type":"4"}},{"id":997930,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-18T00:56:39.000Z","date":"2025-11-13","kind":"exercise","planned":true,"acquired":true,"shares":12220,"price":7.51,"value":91772.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on August 14, 2025, by the Reporting Person, with a plan end date of November 2, 2026."}],"balance_after":62627,"source":{"system":"sec-edgar","filing":"0001866171-25-000007","document":"wk-form4_1763427396.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000186617125000007/wk-form4_1763427396.xml","form_type":"4"}},{"id":997929,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-18T00:56:39.000Z","date":"2025-11-13","kind":"exercise","planned":true,"acquired":true,"shares":27052,"price":8.63,"value":233458.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on August 14, 2025, by the Reporting Person, with a plan end date of November 2, 2026."}],"balance_after":50407,"source":{"system":"sec-edgar","filing":"0001866171-25-000007","document":"wk-form4_1763427396.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000186617125000007/wk-form4_1763427396.xml","form_type":"4"}},{"id":1064133,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:15:10.000Z","date":"2025-08-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5813,"price":2.75,"value":15985.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards."}],"balance_after":102846,"source":{"system":"sec-edgar","filing":"0001415889-25-022222","document":"form4-08182025_080805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000141588925022222/form4-08182025_080805.xml","form_type":"4"}},{"id":1064132,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:15:10.000Z","date":"2025-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1341,"price":2.13,"value":2856.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards."}],"balance_after":108659,"source":{"system":"sec-edgar","filing":"0001415889-25-022222","document":"form4-08182025_080805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000141588925022222/form4-08182025_080805.xml","form_type":"4"}},{"id":1109941,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-17T00:17:16.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":20568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 12, 2025, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date."}],"balance_after":20568,"derivative":{"exercise_price":13.5,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":20568},"source":{"system":"sec-edgar","filing":"0002065881-25-000024","document":"wk-form4_1750119429.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000206588125000024/wk-form4_1750119429.xml","form_type":"4"}},{"id":1109940,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-17T00:17:16.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":7609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 12, 2025, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. Upon vesting of the RSUs, the settlement has been deferred by the Reporting Person, pursuant to the terms of the RSU Deferral Election Form adopted on November 15,  2024, maintained by the Company."}],"balance_after":23355,"source":{"system":"sec-edgar","filing":"0002065881-25-000024","document":"wk-form4_1750119429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000206588125000024/wk-form4_1750119429.xml","form_type":"4"}},{"id":1238721,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-28T22:15:08.000Z","date":"2025-02-26","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan."}],"balance_after":110000,"source":{"system":"sec-edgar","filing":"0001415889-25-006034","document":"form4-02282025_050204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000141588925006034/form4-02282025_050204.xml","form_type":"4"}},{"id":1407786,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-13T20:15:13.000Z","date":"2024-09-12","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001415889-24-023361","document":"form4-09132024_040906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000141588924023361/form4-09132024_040906.xml","form_type":"4"}},{"id":1475655,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-18T20:51:53.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":27052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 14, 2024, subject to the non-employee director's continuous service."}],"balance_after":27052,"derivative":{"exercise_price":8.63,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":27052},"source":{"system":"sec-edgar","filing":"0001787306-24-000102","document":"wk-form4_1718743906.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000178730624000102/wk-form4_1718743906.xml","form_type":"4"}},{"id":1475654,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-18T20:51:53.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":10139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders.  The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.  The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":15746,"source":{"system":"sec-edgar","filing":"0001787306-24-000102","document":"wk-form4_1718743906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000178730624000102/wk-form4_1718743906.xml","form_type":"4"}},{"id":1546896,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-05T20:55:33.000Z","date":"2024-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":215000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was cancelled  pursuant to the Merger Agreement in exchange for one CVR for each share underlying such out-of-the-money option. However, please note that such CVRs will provide payment only after the amounts payable under such CVRs exceed a threshold equal to the excess of the per share exercise price of such out-of-the-money option over the Cash Amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled  pursuant to the Merger Agreement in exchange for one CVR for each share underlying such out-of-the-money option. However, please note that such CVRs will provide payment only after the amounts payable under such CVRs exceed a threshold equal to the excess of the per share exercise price of such out-of-the-money option over the Cash Amount."}],"balance_after":0,"derivative":{"exercise_price":6.78,"expiration_date":"2033-02-10","underlying":"Common Stock","underlying_shares":215000},"source":{"system":"sec-edgar","filing":"0001415889-24-010431","document":"form4-04052024_040421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000141588924010431/form4-04052024_040421.xml","form_type":"4"}},{"id":1546895,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-05T20:55:33.000Z","date":"2024-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":185000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was cancelled  pursuant to the Merger Agreement in exchange for one CVR for each share underlying such out-of-the-money option. However, please note that such CVRs will provide payment only after the amounts payable under such CVRs exceed a threshold equal to the excess of the per share exercise price of such out-of-the-money option over the Cash Amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled  pursuant to the Merger Agreement in exchange for one CVR for each share underlying such out-of-the-money option. However, please note that such CVRs will provide payment only after the amounts payable under such CVRs exceed a threshold equal to the excess of the per share exercise price of such out-of-the-money option over the Cash Amount."}],"balance_after":0,"derivative":{"exercise_price":10.03,"expiration_date":"2032-02-11","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001415889-24-010431","document":"form4-04052024_040421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000141588924010431/form4-04052024_040421.xml","form_type":"4"}},{"id":1546894,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-05T20:55:33.000Z","date":"2024-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":270000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was cancelled  pursuant to the Merger Agreement in exchange for one CVR for each share underlying such out-of-the-money option. However, please note that such CVRs will provide payment only after the amounts payable under such CVRs exceed a threshold equal to the excess of the per share exercise price of such out-of-the-money option over the Cash Amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled  pursuant to the Merger Agreement in exchange for one CVR for each share underlying such out-of-the-money option. However, please note that such CVRs will provide payment only after the amounts payable under such CVRs exceed a threshold equal to the excess of the per share exercise price of such out-of-the-money option over the Cash Amount."}],"balance_after":0,"derivative":{"exercise_price":23.26,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0001415889-24-010431","document":"form4-04052024_040421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000141588924010431/form4-04052024_040421.xml","form_type":"4"}},{"id":1546893,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-04-05T20:55:33.000Z","date":"2024-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":64087,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 42,188 shares represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Disposed of pursuant to that certain Agreement and Plan of Merger, dated February 16, 2024, by and between the Issuer, XOMA Corporation and XRA 1 Corp. (the \"Merger Agreement\") in exchange for (i) $2.5879 in cash per share (the \"Cash Amount\"), plus (ii) one non-transferable contingent value right (\"CVR\") per share. Each RSU will receive the Cash Amount (without interest and less any applicable tax withholdings), plus one CVR."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-010431","document":"form4-04052024_040421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000141588924010431/form4-04052024_040421.xml","form_type":"4"}},{"id":1597419,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-05T22:00:59.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1506,"price":2.59,"value":3900.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were forfeited to cover a tax obligation resulting form the quarterly vesting of restricted stock units (\"RSUs\") granted to the Reporting Person by the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 42,188 shares represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer. A portion of the RSUs vest each quarter, subject to the Reporting Person's continued service as of each vesting date."}],"balance_after":64087,"source":{"system":"sec-edgar","filing":"0001415889-24-006755","document":"form4-03052024_050310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000141588924006755/form4-03052024_050310.xml","form_type":"4"}},{"id":1722111,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-05T22:00:18.000Z","date":"2023-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1459,"price":2.25,"value":3282.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were forfeited to cover a tax obligation resulting form the quarterly vesting of restricted stock units (\"RSUs\") granted to the Reporting Person by the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 46,407 shares represented by restricted stock units (\"RSUs\").  Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer.  A portion of the RSUs vest each quarter, subject to the Reporting Person's continued service as of each vesting date."}],"balance_after":65593,"source":{"system":"sec-edgar","filing":"0001209191-23-057455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000120919123057455/doc4.xml","form_type":"4"}},{"id":1787441,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-06T21:00:32.000Z","date":"2023-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1459,"price":2.35,"value":3428.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were forfeited to cover a tax obligation resulting form the quarterly vesting of RSU's granted to the Reporting Person by the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 50,625 shares represented by restricted stock units (\"RSUs\").  Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer.  A portion of the RSUs vest each quarter, subject to the Reporting Person's continued service as of each vesting date."}],"balance_after":67052,"source":{"system":"sec-edgar","filing":"0001209191-23-048429","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000120919123048429/doc4.xml","form_type":"4"}},{"id":1867405,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-05T21:00:38.000Z","date":"2023-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1459,"price":4.3,"value":6273.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were forfeited to cover a tax obligation resulting form the quarterly vesting of RSU's granted to the Reporting Person by the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,844 shares represented by restricted stock units (\"RSUs\").  Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer.  A portion of the RSUs vest each quarter, subject to the Reporting Person's continued service as of each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,592 shares acquired under the Issuers Employee Stock Purchase Plan in May 2023."}],"balance_after":68511,"source":{"system":"sec-edgar","filing":"0001209191-23-034447","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000120919123034447/doc4.xml","form_type":"4"}},{"id":1870293,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T22:59:26.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":12220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023."}],"balance_after":12220,"derivative":{"exercise_price":7.51,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":12220},"source":{"system":"sec-edgar","filing":"0001787306-23-000052","document":"wk-form4_1685746757.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000178730623000052/wk-form4_1685746757.xml","form_type":"4"}},{"id":1870292,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T22:59:26.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":4375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,375 Restricted Stock Units (?RSUs?). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":5607,"source":{"system":"sec-edgar","filing":"0001787306-23-000052","document":"wk-form4_1685746757.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000178730623000052/wk-form4_1685746757.xml","form_type":"4"}},{"id":1974645,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T22:56:28.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":1721,"price":5.21,"value":8966.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were forfeited to cover a tax obligation resulting form the quarterly vesting of RSU's granted to the Reporting Person by the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 59,063 shares represented by restricted stock units (\"RSUs\").  Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer.  A portion of the RSUs vest each quarter, subject to the Reporting Person's continued service as of each vesting date."}],"balance_after":67378,"source":{"system":"sec-edgar","filing":"0001209191-23-015868","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000120919123015868/doc4.xml","form_type":"4"}},{"id":2016882,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-14T22:00:27.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":215000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One forty-eighth (1/48th) of the total number of shares granted under the Option shall vest and become exercisable starting on March 1, 2023 (the \"Vesting Commencement Date\") and thereafter each month on the same day of the month as the Vesting Commencement Date, until all shares subject to the Option have vested on February 1, 2027, subject to the Reporting Person continuing to be a service provider through each such date."}],"balance_after":215000,"derivative":{"exercise_price":6.78,"expiration_date":"2033-02-10","underlying":"Common Stock","underlying_shares":215000},"source":{"system":"sec-edgar","filing":"0001209191-23-009207","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000120919123009207/doc4.xml","form_type":"4"}},{"id":2098588,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-03T01:00:15.000Z","date":"2022-12-01","kind":"tax_withholding","acquired":false,"shares":1459,"price":7.75,"value":11307.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,543 shares acquired under the Issuer's Employee Stock Purchase Plan in November 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 63,282 shares represented by restricted stock units (\"RSUs\").  Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer.  A portion of the RSUs vest each quarter, subject to the Reporting Person's continued service as of each vesting date."}],"balance_after":69099,"source":{"system":"sec-edgar","filing":"0001209191-22-059514","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000120919122059514/doc4.xml","form_type":"4"}},{"id":2165950,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-06T23:08:12.000Z","date":"2022-09-02","kind":"grant","acquired":true,"shares":29482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/3rd of the total shares on each of September 2, 2023, September 2, 2024 and September 2, 2025, subject to Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":29482,"derivative":{"exercise_price":24.11,"expiration_date":"2032-09-02","underlying":"Common Stock","underlying_shares":29482},"source":{"system":"sec-edgar","filing":"0001567619-22-017088","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000156761922017088/doc1.xml","form_type":"4"}},{"id":2167817,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-02T21:00:20.000Z","date":"2022-09-01","kind":"grant","acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer granted RSUs to the Reporting Person. Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer. A portion of the RSUs vest each quarter, subject to the Reporting Person's continued service as of each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,515 shares acquired under the Issuer's Employee Stock Purchase Plan in May 2022."}],"balance_after":69015,"source":{"system":"sec-edgar","filing":"0001209191-22-048526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000120919122048526/doc4.xml","form_type":"4"}},{"id":2394788,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-15T21:01:01.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One forty-eighth (1/48th) of the total number of shares granted under the Option shall vest and become exercisable starting on March 1, 2022 (the \"Vesting Commencement Date\") and thereafter each month on the same day of the month as the Vesting Commencement Date, until all shares subject to the Option have vested on February 1, 2026, subject to the Reporting Person continuing to be a service provider through each such date."}],"balance_after":185000,"derivative":{"exercise_price":10.03,"expiration_date":"2032-02-11","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001209191-22-009741","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000120919122009741/doc4.xml","form_type":"4"}},{"id":2677932,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25938,"kind":"person","name":"Krishnamohan Neha","position":1,"cik":"0001866171","reported_name":"Krishnamohan Neha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-06-09T00:32:03.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":270000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares underlying the Option shall vest and become exercisable one year from the date of grant (the \"Vest Base Date\"), and 1/36th of the remaining shares subject to the Option shall vest thereafter on the same day of the month as the Vest Base Date."}],"balance_after":270000,"derivative":{"exercise_price":23.26,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0001209191-21-039065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866171/000120919121039065/doc4.xml","form_type":"4"}}]}